The search for NPFFR2: A drug target and biomarker for GPR74 (G10886)

Target Name: NPFFR2

NCBI ID: G10886

The search for NPFFR2: A drug target and biomarker for GPR74

G-protein-coupled receptors (GPCRs) are a family of transmembrane proteins that play a crucial role in cellular signaling. GPCRs are involved in various physiological processes, including sensory perception, neurotransmission, and hormone signaling. GPR74 is a GPCR that has been extensively studied for its role in neurotransmission and behavior. The activation of GPR74 by ligands can result in the neurotransmitter neurotransmitter release, which is critical for the function of many psychiatric and neurological disorders.

NPFFR2, a GPCR-related protein, has been identified as a potential drug target and biomarker for GPR74. NPFFR2 is a 25-kDa protein that is expressed in various tissues and cells, including brain, heart, and peripheral tissues. It is highly homophilic and has a predicted transmembrane protein structure. Several studies have identified NPFFR2 as a potential drug target for GPR74 due to its high intercellular signaling potential and its expression in GPCR-mediated signaling pathways.

Drug targeting GPR74

GPR74 is a validated drug target for several psychiatric and neurological disorders, including depression, anxiety, and schizophrenia. The use of selective GPCR antagonists, such as rapamycin and gefitinib, has been shown to be effective in treating these disorders. However, the use of these drugs is limited by their side effects and limited efficacy. The search for a more effective and selective GPCR antagonist has led to the development of NPFFR2 as a potential drug target for GPR74.

Biomarker development

NPFFR2 has been identified as a potential biomarker for GPR74 due to its involvement in the neurotransmission of various psychiatric and neurological disorders. Several studies have shown that NPFFR2 is involved in the regulation of neurotransmitter release, including the regulation of dopamine release in the brain. Additionally, NPFFR2 has been shown to play a role in the modulation of pain perception and anxiety.

NPFFR2 has also been shown to be involved in the regulation of intracellular signaling pathways, including the regulation of tyrosine signaling pathway. This pathway is involved in the regulation of neurotransmitter release and is a key regulator of psychiatric and neurological disorders. The modulation of tyrosine signaling pathway by NPFFR2 has been shown to play a role in the regulation of neurotransmission in various psychiatric and neurological disorders.

Conclusion

NPFFR2 is a GPCR-related protein that has been identified as a potential drug target for GPR74. Its involvement in the neurotransmission of various psychiatric and neurological disorders makes it a promising biomarker for GPR74. The development of NPFFR2 as a potential drug target and biomarker for GPR74 has the potential to improve the treatment of psychiatric and neurological disorders. Further research is needed to fully understand the role of NPFFR2 in neurotransmission and its potential as a drug target and biomarker for GPR74.

Protein Name: Neuropeptide FF Receptor 2

Functions: Receptor for NPAF (A-18-F-amide) and NPFF (F-8-F-amide) neuropeptides, also known as morphine-modulating peptides. Can also be activated by a variety of naturally occurring or synthetic FMRF-amide like ligands. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system

More Common Targets